Datagov Opendata Platform

The Health Insurance Administration has selected evidence-based medical indicator items to be made public in order to enhance the quality of medical care for patients with myocardial infarction. These items serve as a reference for relevant disease treatment or healthcare quality; the public items are divided into three categories according to the treatment period and quality dimensions, including inpatient process assessment, post-discharge ongoing medication treatment assessment, and outcome assessment. This includes the ratio of inpatients with acute myocardial infarction (AMI) undergoing LDL cholesterol testing during hospitalization, the medication ratio for AMI patients during hospitalization, and within three, six, and nine months post-discharge, the rate of emergency room revisits within three days of discharge for the same main diagnosis or related condition, and the unplanned readmission rate within fourteen days of discharge for the same main diagnosis or related condition.